John I. Brewer Trophoblastic Disease Center
|
The John I. Brewer Trophoblastic Disease Center of Northwestern University's Feinberg School of Medicine (Brewer Center) was established within the Department of Obstetrics and Gynecology in 1962.
The center studies and treats gestational trophoblastic diseases. These include rare growth disturbances of the placenta such as hydatidiform mole, invasive mole, choriocarcinoma, and placental site trophoblastic tumor. The center serves as a treatment facility for patients with trophoblastic diseases, a consultation service for physicians and patients, and a clinical and laboratory research unit. More than 6,000 patients have been referred to the Brewer Center from 42 states and seven foreign countries, including approximately 850 who have received treatment for trophoblastic tumors at the center. Gestational trophoblastic tumors are rare and require a multimodality approach for successful treatment. With current therapies, trophoblastic tumors are now nearly universally curable. Almost all patients treated primarily at the Brewer Trophoblastic Disease Center since 1980 have been cured. |
|
